FTRE
Fortrea Holdings Inc.
Company overview
- Market capitalization
- $1.91B
- Employees
- 14,000
- Latest publication
- 2026-09-29
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD | Q1 20222022-03-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 678,200,000USD | 636,500,000USD | 660,500,000USD | 762,300,000USD | 793,100,000USD | 779,000,000USD |
| Cost Of Revenue | 539,000,000USD | 532,700,000USD | 548,700,000USD | 594,800,000USD | 637,700,000USD | 661,700,000USD |
| Gross Profit | 139,200,000USD | 103,800,000USD | 111,800,000USD | 167,500,000USD | 155,400,000USD | 117,300,000USD |
| Selling General Administrative | 102,100,000USD | 100,500,000USD | 103,000,000USD | 70,700,000USD | 71,200,000USD | — |
| Total Operating Expenses | 124,400,000USD | 100,500,000USD | 103,000,000USD | 98,600,000USD | 71,200,000USD | 75,000,000USD |
| Operating Income | 14,800,000USD | 3,300,000USD | 8,800,000USD | 68,900,000USD | 84,200,000USD | 42,300,000USD |
| Total Other Income Expense Net | -16,000,000USD | -15,600,000USD | -44,400,000USD | 5,300,000USD | -600,000USD | -4,800,000USD |
| Depreciation And Amortization | 19,600,000USD | 19,800,000USD | 19,300,000USD | 22,700,000USD | 27,500,000USD | 30,400,000USD |
| Income Before Tax | -1,200,000USD | -12,300,000USD | -35,600,000USD | 74,200,000USD | 83,600,000USD | 37,500,000USD |
| Income Tax Expense | 12,000,000USD | 11,300,000USD | -3,100,000USD | 13,600,000USD | 17,200,000USD | 5,000,000USD |
| Net Income | -13,200,000USD | -23,600,000USD | -32,500,000USD | 60,600,000USD | 66,400,000USD | 32,500,000USD |
| Interest Expense | — | 18,900,000USD | 23,200,000USD | 0USD | 0USD | — |
| Net Interest Income | — | -19,100,000USD | -23,200,000USD | 0USD | 0USD | — |
| Tax Provision | — | 11,300,000USD | -3,100,000USD | 13,600,000USD | 17,200,000USD | — |
| Net Income From Continuing Ops | — | -23,600,000USD | -32,500,000USD | 60,600,000USD | 66,400,000USD | — |
| Ebit | — | 6,600,000USD | -12,400,000USD | 74,200,000USD | 83,600,000USD | 37,500,000USD |
| Ebitda | — | 26,400,000USD | 6,900,000USD | 96,900,000USD | 111,100,000USD | 67,900,000USD |
| Reconciled Depreciation | — | 19,800,000USD | 19,300,000USD | 22,700,000USD | 23,400,000USD | — |
| Unclassified Operating Expenses | — | — | — | 27,900,000USD | — | 75,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20212021-12-31 · USD |
|---|---|
| Total Revenue | 3,057,500,000USD |
| Cost Of Revenue | 2,453,100,000USD |
| Gross Profit | 604,400,000USD |
| Selling General Administrative | 303,100,000USD |
| Unclassified Operating Expenses | 187,000,000USD |
| Total Operating Expenses | 490,100,000USD |
| Operating Income | 114,300,000USD |
| Interest Expense | 200,000USD |
| Net Interest Income | -200,000USD |
| Income Before Tax | 136,400,000USD |
| Income Tax Expense | 38,400,000USD |
| Tax Provision | 38,400,000USD |
| Net Income | 98,000,000USD |
| Net Income From Continuing Ops | 98,000,000USD |
| Ebit | 136,600,000USD |
| Ebitda | 302,900,000USD |
| Depreciation And Amortization | 166,300,000USD |
| Reconciled Depreciation | 166,300,000USD |
| Total Other Income Expense Net | 22,100,000USD |
| Source | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,714,900,000USD | 2,683,400,000USD | 2,715,700,000USD | 2,742,100,000USD | 2,835,100,000USD | 3,121,100,000USD | 3,579,200,000USD | 3,663,700,000USD |
| Cash And Equivalents | 168,600,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 923,600,000USD | 881,500,000USD | 897,200,000USD | 918,500,000USD | 960,000,000USD | 970,300,000USD | 948,200,000USD | 936,900,000USD |
| Other Current Assets | 100,600,000USD | 114,400,000USD | 102,600,000USD | 124,000,000USD | 139,600,000USD | 139,700,000USD | 135,700,000USD | 142,500,000USD |
| Other Non Current Assets | 91,800,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,190,700,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 963,700,000USD | 929,100,000USD | 913,300,000USD | 914,400,000USD | 942,300,000USD | 999,100,000USD | 949,500,000USD | 795,800,000USD |
| Other Current Liabilities | 380,800,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 38,500,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 524,200,000USD | 525,900,000USD | 563,500,000USD | 580,800,000USD | 589,200,000USD | 858,800,000USD | 1,362,400,000USD | 1,513,500,000USD |
| Total Equity Including Noncontrolling Interest | 524,200,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 17,100,000USD | 10,900,000USD | 4,800,000USD | 74,500,000USD | 74,800,000USD | 163,800,000USD | 74,800,000USD | — |
| Long Term Debt | 1,037,200,000USD | 1,042,600,000USD | 1,048,000,000USD | 1,052,100,000USD | 1,100,900,000USD | 1,049,900,000USD | 1,049,700,000USD | 1,124,500,000USD |
| Deferred Revenue | 502,700,000USD | — | — | — | — | — | — | — |
| Goodwill | 950,300,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 586,800,000USD | 601,700,000USD | 622,000,000USD | 635,400,000USD | 654,300,000USD | 651,300,000USD | 655,700,000USD | 691,200,000USD |
| Accounts Payable | 54,200,000USD | 70,800,000USD | 29,700,000USD | 49,500,000USD | 92,600,000USD | 110,200,000USD | 138,200,000USD | 137,600,000USD |
| Short Term Debt | 8,900,000USD | 19,700,000USD | 14,000,000USD | 83,700,000USD | 87,200,000USD | 177,300,000USD | 88,200,000USD | 14,000,000USD |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Retained Earnings | -1,420,000,000USD | -1,406,800,000USD | -1,383,200,000USD | -1,350,700,000USD | -1,334,800,000USD | -959,900,000USD | -397,000,000USD | -335,800,000USD |
| Accumulated Other Comprehensive Income | -196,500,000USD | -195,400,000USD | -170,000,000USD | -170,400,000USD | -155,600,000USD | -238,200,000USD | -282,900,000USD | -178,100,000USD |
| Total Liab | — | 2,157,500,000USD | 2,152,200,000USD | 2,161,300,000USD | 2,245,900,000USD | 2,262,300,000USD | 2,216,800,000USD | 2,150,200,000USD |
| Other Current Liab | — | 357,300,000USD | 395,800,000USD | 369,600,000USD | 380,800,000USD | 347,200,000USD | 317,100,000USD | 323,100,000USD |
| Capital Stock | — | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Good Will | — | 950,800,000USD | 960,000,000USD | 958,100,000USD | 965,200,000USD | 1,242,500,000USD | 1,710,400,000USD | 1,767,000,000USD |
| Cash | — | 147,500,000USD | 174,600,000USD | 131,300,000USD | 81,200,000USD | 101,600,000USD | 118,500,000USD | 105,300,000USD |
| Cash And Short Term Investments | — | 147,500,000USD | 174,600,000USD | 131,300,000USD | 81,200,000USD | 101,600,000USD | 118,500,000USD | 105,300,000USD |
| Current Deferred Revenue | — | 481,300,000USD | 473,800,000USD | 411,600,000USD | 381,700,000USD | 364,400,000USD | 353,300,000USD | 321,100,000USD |
| Net Debt | — | 970,500,000USD | 941,400,000USD | 1,056,000,000USD | 1,159,800,000USD | 1,184,700,000USD | 1,080,000,000USD | 1,098,600,000USD |
| Short Long Term Debt Total | — | 1,118,000,000USD | 1,116,000,000USD | 1,187,300,000USD | 1,241,000,000USD | 1,286,300,000USD | 1,198,500,000USD | 1,203,900,000USD |
| Net Receivables | — | 619,600,000USD | 620,000,000USD | 663,200,000USD | 739,200,000USD | 729,000,000USD | 694,000,000USD | 689,100,000USD |
| Property Plant Equipment Net | — | 157,100,000USD | 149,500,000USD | 147,600,000USD | 148,700,000USD | 150,200,000USD | 156,300,000USD | 173,100,000USD |
| Common Stock Shares Outstanding | — | 91,200,000shares | 91,200,000shares | 91,200,000shares | 90,600,000shares | 89,400,000shares | 90,000,000shares | 90,000,000shares |
| Non Current Assets Total | — | 1,801,900,000USD | 1,818,500,000USD | 1,823,600,000USD | 1,875,100,000USD | 2,150,800,000USD | 2,631,000,000USD | 2,726,800,000USD |
| Non Current Liabilities Total | — | 1,228,400,000USD | 1,238,900,000USD | 1,246,900,000USD | 1,303,600,000USD | 1,263,200,000USD | 1,267,300,000USD | 1,354,400,000USD |
| Non Current Liabilities Other | — | 37,800,000USD | 39,300,000USD | 36,400,000USD | 37,000,000USD | 36,300,000USD | 35,300,000USD | 37,600,000USD |
| Non Currrent Assets Other | — | 86,100,000USD | 80,800,000USD | 74,200,000USD | 101,300,000USD | 101,400,000USD | 103,400,000USD | 92,300,000USD |
| Net Working Capital | — | -47,600,000USD | -16,100,000USD | 4,100,000USD | 17,700,000USD | -28,800,000USD | -1,300,000USD | 141,100,000USD |
| Unclassified Current Liabilities | — | -10,900,000USD | — | -74,500,000USD | -74,800,000USD | -163,800,000USD | -22,100,000USD | — |
| Unclassified Non Current Liabilities | — | 148,000,000USD | 151,600,000USD | 158,400,000USD | 165,700,000USD | 177,000,000USD | 182,300,000USD | 192,300,000USD |
| Unclassified Equity | — | 2,127,900,000USD | 2,116,500,000USD | 2,101,700,000USD | 2,079,400,000USD | 2,056,700,000USD | 2,042,100,000USD | 2,027,200,000USD |
| Property Plant Equipment Gross | — | — | 332,800,000USD | — | — | — | 320,400,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 2,715,700,000USD | 3,579,200,000USD | 4,332,600,000USD | 4,287,900,000USD | 4,368,700,000USD | — |
| Intangible Assets | 622,000,000USD | 655,700,000USD | 728,100,000USD | 823,300,000USD | 935,500,000USD | — |
| Other Current Assets | 102,600,000USD | 135,700,000USD | 131,700,000USD | 83,500,000USD | 73,100,000USD | — |
| Total Liab | 2,152,200,000USD | 2,216,800,000USD | 2,618,500,000USD | 945,300,000USD | 1,108,100,000USD | — |
| Total Stockholder Equity | 563,500,000USD | 1,362,400,000USD | 1,714,100,000USD | 3,342,600,000USD | 3,260,600,000USD | — |
| Other Current Liab | 395,800,000USD | 317,100,000USD | 328,000,000USD | 283,200,000USD | 394,700,000USD | — |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | — | — | — |
| Capital Stock | 100,000USD | 100,000USD | 100,000USD | 0USD | — | — |
| Retained Earnings | -1,383,200,000USD | -397,000,000USD | -68,500,000USD | -276,000,000USD | -148,400,000USD | — |
| Good Will | 960,000,000USD | 1,710,400,000USD | 1,739,400,000USD | 1,997,300,000USD | 2,080,900,000USD | — |
| Cash | 174,600,000USD | 118,500,000USD | 108,600,000USD | 112,000,000USD | 94,600,000USD | — |
| Cash And Short Term Investments | 174,600,000USD | 118,500,000USD | 108,600,000USD | 112,000,000USD | 94,600,000USD | — |
| Total Current Assets | 897,200,000USD | 948,200,000USD | 1,250,800,000USD | 1,246,900,000USD | 1,117,500,000USD | — |
| Total Current Liabilities | 913,300,000USD | 949,500,000USD | 778,400,000USD | 699,000,000USD | 826,700,000USD | — |
| Current Deferred Revenue | 473,800,000USD | 353,300,000USD | 214,200,000USD | 271,500,000USD | 307,000,000USD | — |
| Net Debt | 941,400,000USD | 1,080,000,000USD | 1,563,400,000USD | -48,600,000USD | -17,400,000USD | — |
| Short Term Debt | 14,000,000USD | 88,200,000USD | 43,300,000USD | 23,300,000USD | 24,000,000USD | — |
| Short Long Term Debt | 4,800,000USD | 74,800,000USD | 26,100,000USD | — | — | — |
| Short Long Term Debt Total | 1,116,000,000USD | 1,198,500,000USD | 1,672,000,000USD | 63,400,000USD | 77,200,000USD | — |
| Long Term Debt | 1,048,000,000USD | 1,049,700,000USD | 1,565,900,000USD | — | — | — |
| Net Receivables | 620,000,000USD | 694,000,000USD | 1,010,500,000USD | 1,051,400,000USD | 949,800,000USD | — |
| Accounts Payable | 29,700,000USD | 138,200,000USD | 132,900,000USD | 81,500,000USD | 60,500,000USD | — |
| Property Plant Equipment Net | 149,500,000USD | 156,300,000USD | 172,600,000USD | 164,900,000USD | 162,600,000USD | — |
| Property Plant Equipment Gross | 332,800,000USD | 320,400,000USD | 389,800,000USD | 293,600,000USD | 274,800,000USD | — |
| Accumulated Other Comprehensive Income | -170,000,000USD | -282,900,000USD | -215,500,000USD | -276,000,000USD | -148,400,000USD | — |
| Common Stock Shares Outstanding | 91,200,000shares | 89,500,000shares | 88,800,000shares | 88,400,000shares | 88,400,000shares | 88,400,000shares |
| Non Current Assets Total | 1,818,500,000USD | 2,631,000,000USD | 3,081,800,000USD | 3,041,000,000USD | 3,251,200,000USD | — |
| Non Current Liabilities Total | 1,238,900,000USD | 1,267,300,000USD | 1,840,100,000USD | 246,300,000USD | 281,400,000USD | — |
| Non Current Liabilities Other | 39,300,000USD | 35,300,000USD | 61,300,000USD | 21,700,000USD | 17,900,000USD | — |
| Non Currrent Assets Other | 80,800,000USD | 103,400,000USD | 438,500,000USD | 54,300,000USD | 70,800,000USD | — |
| Net Working Capital | -16,100,000USD | -1,300,000USD | 477,200,000USD | 547,900,000USD | 290,800,000USD | — |
| Unclassified Non Current Liabilities | 151,600,000USD | 182,300,000USD | 212,900,000USD | 224,600,000USD | 263,500,000USD | — |
| Unclassified Equity | 2,116,500,000USD | 2,042,100,000USD | 1,997,900,000USD | 3,894,600,000USD | 3,557,400,000USD | — |
| Unclassified Current Liabilities | — | -22,100,000USD | 33,900,000USD | 39,500,000USD | 40,500,000USD | — |
| Inventory | — | — | 35,300,000USD | — | — | — |
| Unclassified Current Assets | — | — | -35,300,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,600,000USD | -32,500,000USD | -15,900,000USD | -374,900,000USD | -562,900,000USD | -73,900,000USD | -27,900,000USD | -138,400,000USD |
| Depreciation | 19,800,000USD | 19,300,000USD | 19,600,000USD | 19,600,000USD | 19,500,000USD | 20,800,000USD | 21,200,000USD | 21,400,000USD |
| Stock Based Compensation | 11,400,000USD | 14,800,000USD | 22,300,000USD | 22,700,000USD | 14,600,000USD | 15,300,000USD | 13,000,000USD | 15,000,000USD |
| Other Non Cash Items | -2,800,000USD | 2,300,000USD | 8,200,000USD | 354,300,000USD | 499,800,000USD | 37,400,000USD | 32,000,000USD | 40,800,000USD |
| Change To Account Receivables | -33,700,000USD | 81,500,000USD | 66,900,000USD | -7,000,000USD | -70,500,000USD | 19,000,000USD | -56,000,000USD | 312,200,000USD |
| Change In Working Capital | -17,800,000USD | 132,800,000USD | 60,200,000USD | 10,300,000USD | -88,600,000USD | 34,200,000USD | -29,100,000USD | 350,700,000USD |
| Total Cash From Operating Activities | -17,000,000USD | 129,100,000USD | 86,800,000USD | 21,800,000USD | -124,200,000USD | 17,100,000USD | -2,400,000USD | 273,700,000USD |
| Capital Expenditures | -8,000,000USD | -7,500,000USD | -7,300,000USD | -7,500,000USD | -2,900,000USD | 3,200,000USD | -8,200,000USD | -11,200,000USD |
| Free Cash Flow | -25,000,000USD | 121,600,000USD | 79,500,000USD | 14,300,000USD | -127,100,000USD | 20,300,000USD | -10,600,000USD | 262,500,000USD |
| Total Cashflows From Investing Activities | -8,000,000USD | -7,500,000USD | 13,300,000USD | -7,500,000USD | 16,100,000USD | 3,500,000USD | -8,100,000USD | 265,400,000USD |
| Net Borrowings | 0USD | -75,700,000USD | -50,000,000USD | -39,000,000USD | 89,000,000USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 0USD | -75,700,000USD | -50,000,000USD | -39,000,000USD | 88,400,000USD | -1,100,000USD | -14,000,000USD | -504,000,000USD |
| Change In Cash | -27,100,000USD | 43,299,999USD | 50,100,000USD | -20,400,000USD | -16,900,000USD | 13,200,000USD | -20,900,000USD | 33,400,000USD |
| Begin Period Cash Flow | 174,600,000USD | 131,300,000USD | 81,200,000USD | 101,600,000USD | 118,500,000USD | 105,300,000USD | 126,200,000USD | 92,800,000USD |
| End Period Cash Flow | 147,500,000USD | 174,600,000USD | 131,300,000USD | 81,200,000USD | 101,600,000USD | 118,500,000USD | 105,300,000USD | 126,200,000USD |
| Unclassified Operating Cash Flow | -4,000,000USD | -7,600,000USD | -7,600,000USD | -10,200,000USD | -6,600,000USD | -16,700,000USD | -11,600,000USD | -15,800,000USD |
| Other Cashflows From Investing Activities | — | -19,000,000USD | 20,600,000USD | 19,000,000USD | 19,000,000USD | 3,500,000USD | 100,000USD | 276,600,000USD |
| Other Cashflows From Financing Activities | — | -75,700,000USD | -50,000,000USD | 50,000,000USD | -600,000USD | -400,000USD | -14,000,000USD | 265,400,000USD |
| Unclassified Investing Cash Flow | — | 19,000,000USD | -13,300,000USD | -11,500,000USD | -16,100,000USD | -6,700,000USD | 8,100,000USD | -265,400,000USD |
| Unclassified Financing Cash Flow | — | 75,700,000USD | 50,000,000USD | -50,000,000USD | — | — | — | -769,400,000USD |
| Investments | — | — | 13,300,000USD | -7,500,000USD | 16,100,000USD | 3,500,000USD | -8,100,000USD | 265,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -986,200,000USD | -271,500,000USD | -25,200,000USD | 186,200,000USD | 98,000,000USD | -359,200,000USD |
| Depreciation | 78,000,000USD | 98,000,000USD | 98,000,000USD | 93,600,000USD | 166,300,000USD | 119,000,000USD |
| Stock Based Compensation | 74,400,000USD | 58,400,000USD | 42,700,000USD | 25,400,000USD | 27,500,000USD | 23,100,000USD |
| Other Non Cash Items | 864,600,000USD | 38,000,000USD | 67,600,000USD | 42,200,000USD | 35,400,000USD | 449,400,000USD |
| Change To Account Receivables | 70,900,000USD | 309,900,000USD | -53,400,000USD | -108,400,000USD | -187,600,000USD | -22,600,000USD |
| Change In Working Capital | 114,700,000USD | 364,500,000USD | 26,900,000USD | -248,200,000USD | -127,200,000USD | 8,900,000USD |
| Total Cash From Operating Activities | 113,500,000USD | 262,800,000USD | 168,400,000USD | 82,700,000USD | 169,800,000USD | 200,900,000USD |
| Capital Expenditures | -25,200,000USD | -25,500,000USD | -40,300,000USD | -54,400,000USD | -26,500,000USD | -24,000,000USD |
| Free Cash Flow | 88,300,000USD | 237,300,000USD | 128,100,000USD | 28,300,000USD | 143,300,000USD | 176,900,000USD |
| Total Cashflows From Investing Activities | 14,400,000USD | 251,600,000USD | -31,800,000USD | -54,000,000USD | -26,200,000USD | -161,200,000USD |
| Net Borrowings | -75,700,000USD | -482,700,000USD | 1,616,000,000USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -76,300,000USD | -497,800,000USD | -140,800,000USD | -6,300,000USD | -128,500,000USD | -33,100,000USD |
| Change In Cash | 56,100,000USD | 9,900,000USD | -1,800,000USD | 15,800,000USD | 14,300,000USD | 7,100,000USD |
| Begin Period Cash Flow | 118,500,000USD | 108,600,000USD | 110,400,000USD | 94,600,000USD | 80,300,000USD | 73,200,000USD |
| End Period Cash Flow | 174,600,000USD | 118,500,000USD | 108,600,000USD | 110,400,000USD | 94,600,000USD | 80,300,000USD |
| Other Cashflows From Investing Activities | 39,600,000USD | 500,000USD | 8,500,000USD | 400,000USD | 300,000USD | 300,000USD |
| Other Cashflows From Financing Activities | -76,300,000USD | -15,100,000USD | -1,756,800,000USD | -6,300,000USD | -128,500,000USD | -33,100,000USD |
| Unclassified Operating Cash Flow | -32,000,000USD | -24,600,000USD | -41,600,000USD | -16,500,000USD | -30,200,000USD | -40,300,000USD |
| Unclassified Financing Cash Flow | 75,700,000USD | — | — | — | — | — |
| Investments | — | 251,600,000USD | -31,800,000USD | -54,000,000USD | -26,200,000USD | -161,200,000USD |
| Unclassified Investing Cash Flow | — | 25,000,000USD | 31,800,000USD | 54,000,000USD | 26,200,000USD | 23,700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 219,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | North America | 319,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Other Geographical Areas | 138,800,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 213,900,000 | USD | 0001628280-26-030496 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 296,800,000 | USD | 0001628280-26-030496 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Other Geographical Areas | 125,800,000 | USD | 0001628280-26-030496 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Europe | 219,500,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | North America | 303,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Other Geographical Areas | 137,900,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 851,700,000 | USD | 0001628280-26-012244 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 1,289,600,000 | USD | 0001628280-26-012244 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Geographical Areas | 582,100,000 | USD | 0001628280-26-012244 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 213,200,000 | USD | 0001628280-25-049522 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 332,700,000 | USD | 0001628280-25-049522 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Other Geographical Areas | 155,400,000 | USD | 0001628280-25-049522 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 218,700,000 | USD | 0001965040-25-000050 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 344,300,000 | USD | 0001965040-25-000050 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Other Geographical Areas | 147,300,000 | USD | 0001965040-25-000050 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 200,300,000 | USD | 0001628280-26-030496 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 309,500,000 | USD | 0001628280-26-030496 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Other Geographical Areas | 141,500,000 | USD | 0001628280-26-030496 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe | 204,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | North America | 326,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Other Geographical Areas | 167,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 800,000,000 | USD | 0001628280-26-012244 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 1,269,500,000 | USD | 0001628280-26-012244 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Geographical Areas | 626,900,000 | USD | 0001628280-26-012244 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 191,800,000 | USD | 0001628280-25-049522 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 319,700,000 | USD | 0001628280-25-049522 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Other Geographical Areas | 163,400,000 | USD | 0001628280-25-049522 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 827,500,000 | USD | 0001628280-26-012244 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 1,398,400,000 | USD | 0001628280-26-012244 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Geographical Areas | 616,600,000 | USD | 0001628280-26-012244 |
| FY 2023Yearly · 2023-12-31 | Segment | Clinical Services | 2,839,500,000 | USD | 0001965040-24-000010 |
| FY 2023Yearly · 2023-12-31 | Segment | Enabling Services | 269,500,000 | USD | 0001965040-24-000010 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Clinical Services | 711,700,000 | USD | 0001965040-23-000043 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Enabling Services | 64,700,000 | USD | 0001965040-23-000043 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Clinical Services | 726,100,000 | USD | 0001965040-23-000030 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Enabling Services | 66,900,000 | USD | 0001965040-23-000030 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 841,900,000 | USD | 0001965040-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 1,415,500,000 | USD | 0001965040-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Geographical Areas | 579,600,000 | USD | 0001965040-25-000015 |
| FY 2022Yearly · 2022-12-31 | Segment | Clinical Services | 2,825,400,000 | USD | 0001965040-24-000010 |
| FY 2022Yearly · 2022-12-31 | Segment | Enabling Services | 270,700,000 | USD | 0001965040-24-000010 |
| Q3 2022Quarterly · 2022-09-30 | Segment | Clinical Services | 697,200,000 | USD | 0001965040-23-000043 |
| Q3 2022Quarterly · 2022-09-30 | Segment | Enabling Services | 65,100,000 | USD | 0001965040-23-000043 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Clinical Services | 723,300,000 | USD | 0001965040-23-000030 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Enabling Services | 69,800,000 | USD | 0001965040-23-000030 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 868,400,000 | USD | 0001965040-24-000010 |
| FY 2021Yearly · 2021-12-31 | Geography | North America | 1,649,600,000 | USD | 0001965040-24-000010 |
| FY 2021Yearly · 2021-12-31 | Geography | Other Geographical Areas | 539,500,000 | USD | 0001965040-24-000010 |
| FY 2021Yearly · 2021-12-31 | Segment | Clinical Services | 2,763,500,000 | USD | 0001965040-24-000010 |
| FY 2021Yearly · 2021-12-31 | Segment | Enabling Services | 294,000,000 | USD | 0001965040-24-000010 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.